TrialArthritis care & research2014

Phase III study of the efficacy and safety of subcutaneous versus intravenous tocilizumab monotherapy in patients with rheumatoid arthritis.

Atsushi Ogata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.